Elsevier

Autoimmunity Reviews

Volume 6, Issue 4, March 2007, Pages 223-227
Autoimmunity Reviews

From infection to autoimmunity: A new model for induction of ANCA against the bactericidal/permeability increasing protein (BPI)

https://doi.org/10.1016/j.autrev.2006.08.005Get rights and content

Abstract

Antineutrophil cytoplasmic autoantibodies against the neutrophil granule bactericidal/permeability increasing protein (BPI-ANCA) have been found in diseases of different etiologies, such as cystic fibrosis, TAP deficiency or inflammatory bowel diseases. A common feature of these conditions is the chronic or profuse exposure of the host to Gram-negative bacteria and their endotoxin. BPI plays an important role in killing Gram-negative bacteria as well as neutralization and disposal of their endotoxin. During this interaction BPI can direct the delivery of complexes which contain endotoxin and bacterial outer membrane proteins to antigen presenting cells. Based on recent findings on how complexes of endotoxin and protein antigens need to be processed by dendritic cells in order to become presented on MHC class II molecules, a model can be proposed how Gram-negative bacterial infections can be linked to the generation of autoantibodies against BPI.

Section snippets

Acknowledgements

I am greatly indebted to Dr. Jerrold Weiss for critically reading the manuscript.

Take-home messages

  • Clinical data support a link between Gram-negative bacterial infections and the development of ANCA against the neutrophil granule bactericidal/permeability increasing protein (BPI).

  • BPI does not only kill Gram-negative bacteria and neutralizes their endotoxin but also binds complexes of endotoxin and microbial antigens and delivers them to antigen presenting cells.

  • Recent experimental data from a

References (37)

  • L.J. Beamer et al.

    Crystal structure of human BPI and two bound phospholipids at 2.4 Angstrom resolution

    Science

    (1997)
  • H. Gazzano-Santoro et al.

    High-affinity binding of the bactericidal/permeability increasing protein and a recombinant amino-terminal fragment to the Lipid A region of lipopolysaccharide

    Infect Immun

    (1992)
  • B.A. Mannion et al.

    Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coli

    J Clin Invest

    (1990)
  • M.N. Marra et al.

    Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity

    J Immunol

    (1990)
  • N.M. Iovine et al.

    An opsonic function of the neutrophil bactericidal/permeability increasing protein depends on both its N- and C-terminal domains

    Proc Natl Acad Sci U S A

    (1997)
  • F.R. Kohn et al.

    Protective effect of a recombinant amino-terminal fragment of bactericidal/ permeability-increasing protein in experimental endotoxemia

    J Infect Dis

    (1993)
  • T.L. Gioannini et al.

    Monomeric endotoxin:protein complexes are essential for TLR4-dependent cell activation

    J Endotoxin Res

    (2005)
  • M.H. Zhao et al.

    Bactericidal/permeability increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis

    Clin Exp Immunol

    (1995)
  • Cited by (0)

    View full text